Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.27 USD | +2.68% | -0.39% | +32.55% |
13/05 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.55% | 222.74Cr | |
-4.67% | 1.23TCr | |
-5.19% | 814.08Cr | |
+30.68% | 562.13Cr | |
-8.09% | 424.41Cr | |
-54.66% | 306.33Cr | |
+13.49% | 275.67Cr | |
-1.34% | 240.89Cr | |
-3.55% | 186.6Cr | |
+3.02% | 158.41Cr |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Stephens Starts Myriad Genetics at Equalweight With $22 Price Target